Clinical Trials Logo
  1. Home
  2. Aniridia
  3. NCT05400590

Comparison of the Healing Properties on Corneal Cells of Groth Factor-enriched Plasma and Autologous Serum From Aniridia Patients — CICASAND  

Aniridia Clinical Trial

Official title:
Comparison of the Healing Properties on Corneal Cells of Groth Factor-enriched Plasma and Autologous Serum From Aniridia Patients

Clinical Trial Summary

Keratopathy of patients with aniridia leads to epithelial scarring disorders and a progressive clouding of the cornea linked to this abnormal healing (fibrosis). Treatment with autologous serum is usually undertaken to promote epithelial healing. However, autologous serum does not prevent the formation of fibrosis, whereas growth factor-rich plasma appears to be associated with a reduction in the in vitro expression of fibrosis markers. This study seeks to compare the in vitro healing and anti-fibrotic properties of autologous serum and growth factor rich plasma from aniridia patients and healthy controls.

Clinical Trial Description

Blood collection from aniridia patients and healthy controls, half of which will be used to make autologous serum and the other half to make growth factor rich plasma, used for in vitro studies. A conjunctival impression will also be taken at the inclusion of the patients. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05400590
Study type Observational
Source Fondation Ophtalmologique Adolphe de Rothschild
Contact Amélie YAVCHITZ
Phone (0)1 48 03 64 54
Email ayavchitz@for.paris
Status Recruiting
Phase
Start date May 15, 2023
Completion date September 2025
View Details
See also
  Status Clinical Trial Phase
Completed NCT00758108 - Characterization of WAGR Syndrome and Other Chromosome 11 Gene Deletions
Recruiting NCT05044598 - RAFT - Clinical Trial of RAFT for Aniridia Related Keratopathy Phase 1/Phase 2
Recruiting NCT01793168 - Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Completed NCT00001161 - Abnormalities of the Eye's Anterior Chamber, Iris, Cornea and Lens N/A
Enrolling by invitation NCT03461978 - Ultrahigh-resolution Optical Coherence Tomography Imaging of the Anterior Eye Segment Structures N/A
Recruiting NCT05954403 - National Cohort on Congenital Defects of the Eye
Completed NCT02647359 - Study of Ataluren in Participants With Nonsense Mutation Aniridia Phase 2
Completed NCT03581864 - Clinical Outcomes of Implantationof Black Diaphragm Intraocular Lens in Complete Aniridia and Aphakia Due to Posttraumatic Eye Rupture
Recruiting NCT05562115 - Proteomic Study of Tears From Patients With a PAX6 Mutation N/A
Completed NCT00265590 - Correlation of Gene Abnormalities and Clinical Manifestations of Aniridia N/A
Withdrawn NCT04117880 - A Phase 2 Open Label Extension Study in Participants With Nonsense Mutation Aniridia Phase 2
Active, not recruiting NCT00503893 - Genetics of Wilms' Tumor and/or the Associated Conditions of Aniridia, Hemihypertrophy, and Genitourinary Anomalies
Completed NCT01644552 - Positive Angle Kappa
Completed NCT00812708 - Clinical Evaluation of Morcher Artificial Iris Diaphragms N/A